Aggressive skin allograft rejection in CD28−/− mice independent of the CD40/CD40L costimulatory pathway
- 26 September 2001
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 9 (1) , 13-17
- https://doi.org/10.1016/s0966-3274(01)00043-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathwaysNature, 1996
- Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4Immunity, 1995
- Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptorsImmunity, 1994
- CTLA-4 is a second receptor for the B cell activation antigen B7.The Journal of Experimental Medicine, 1991
- CELLS MEDIATING ALLOGRAFT REJECTIONTransplantation, 1991
- Role of the CD28 receptor in T-cell activationImmunology Today, 1990
- A new member of the immunoglobulin superfamily—CTLA-4Nature, 1987
- CELLS MEDIATING GRAFT REJECTION IN THE MOUSE II. THE LY PHENOTYPES OF CELLS PRODUCING TUMOR ALLOGRAFT REJECTIONTransplantation, 1982
- Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection.The Journal of Experimental Medicine, 1981
- A Theory of Self-Nonself DiscriminationScience, 1970